Working… Menu

Gene Therapy for Achromatopsia (CNGA3) (CNGA3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03758404
Recruitment Status : Recruiting
First Posted : November 29, 2018
Last Update Posted : January 22, 2021
Janssen Research & Development, LLC
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : January 2022